CHILD Co-Director, AllerGen CEO honoured by partners

Dr. Stuart Turvey, Co-Director of the CHILD Cohort Study, and Dr. Diana Royce, President & CEO of AllerGen, both received honours from AllerGen partner organizations in late 2019.

Dr. Stuart Turvey recognized by CSACI

L to R: Dr. Stuart Turvey; Dr. Catherine Biggs receives the award on Dr. Turvey’s behalf from CSACI President Dr. Harold Kim; the award.

The Co-Director of the CHILD Cohort Study, Dr. Stuart Turvey, was awarded the 2019 F. Estelle R. Simons Award for Research by the Canadian Society of Allergy and Clinical Immunology (CSACI).

Dr. Catherine Biggs accepted the award on Dr. Turvey’s behalf at the CSACI Annual Scientific Meeting held in Montreal, QC, in October 2019.

The Award recognizes exemplary research in the field of allergy and immunology.

Dr. Turvey is Professor of Pediatrics at The University of British Columbia, where he holds the Aubrey J. Tingle Professorship in Pediatric Immunology.

Read more about the CSACI Annual Scientific Meeting and its 2019 awardees in CSACI’s Winter 2019 Newsletter

Dr. Diana Royce recognized by CAAIF

Photo:Dr. Royce (R) receives her CAAIF award from CAAIF President Dr. Susan Waserman.

AllerGen President & CEO Dr. Diana Royce was presented with an award of appreciation by the Canadian Allergy, Asthma, and Immunology Foundation (CAAIF) at the CAAIF’s Gala fundraiser on October 24, 2019, in Montreal, QC.

The award recognizes Dr. Royce’s contributions to, and support of, the Foundation.